NPS Pharmaceuticals, Inc. (NPSP) Joins Participants From Around The World In Observing Rare Disease Day
2/28/2014 8:51:48 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Joins Participants From Around The World In Observing Rare Disease Day
2/28/2014 7:35:22 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) To Present At Barclays Global Healthcare Conference
2/27/2014 7:13:04 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Reports Fourth Quarter And Full-Year 2013 Financial Results And Financial Outlook For 2014
2/19/2014 7:02:21 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) To Report 2013 Financial Results
2/6/2014 6:53:24 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Announces FDA Acceptance Of Biologics License Application For Natpara® For The Treatment Of Hypoparathyroidism
1/8/2014 9:17:23 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Reports Preliminary 2013 Results And 2014 Financial Outlook
1/8/2014 8:45:04 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) To Present At J.P. Morgan Healthcare Conference
1/7/2014 7:02:29 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Receives Orphan Drug Designation For Natpara® In Europe
1/3/2014 8:57:04 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Initiates Global Registration Study Of Teduglutide In Pediatric Patients With Short Bowel Syndrome
1/2/2014 9:24:21 AM
More...
|
|